Efficacy and Safety of Lanreotide Autogel® 60, 90 or 120 mg With Lanreotide 40 mg Prolonged Release (PR) in Acromegaly
The purpose is to compare the efficacy and safety of lanreotide autogel® 60mg, 90mg or 120mg with lanreotide 40mg PR in subjects with active acromegaly.
Efficacy and Safety of Lanreotide Autogel® 60, 90 or 120 mg With Lanreotide 40 mg Prolonged Release (PR) in Acromegaly
- 06 novembre 2024 - 1 mn de lecture
The purpose is to compare the efficacy and safety of lanreotide autogel® 60mg, 90mg or 120mg with lanreotide 40mg PR in subjects with active acromegaly.
En rapport Clinical Trials
06 novembre 2024
1 mn de lecture
Neurogenic Detrusor Overactivity Following Spinal Cord Injury or Multiple Sclerosis
06 novembre 2024
1 mn de lecture
Efficacy And Safety Of Dysport In The Treatment Of Upper Limb Spasticity In Children
06 novembre 2024
1 mn de lecture
Dysport® Adult Upper Limb Spasticity Extension Study
06 novembre 2024
1 mn de lecture
Safety and Efficacy Study of Dysport RU and Glabellar Lines
06 novembre 2024
1 mn de lecture
Dysport® Adult Upper Limb Spasticity
06 novembre 2024
1 mn de lecture
Study Comparing Short Term Efficacy of Dysport and Dysport NG to Placebo, and to Assess Efficacy and Safety of Dysport NG of Subjects With Cervical...
06 novembre 2024
1 mn de lecture
Safety/Efficacy of Tigan® to Control Nausea/Vomiting Experienced During Apokyn® Initiation and Treatment
06 novembre 2024
1 mn de lecture
Open-label Extension Study of AbobotulinumtoxinA (Dysport®) for the Treatment of Cervical Dystonia
06 novembre 2024
1 mn de lecture
Study to Assess the Efficacy and Safety of Dysport® in Upper Back Myofascial Pain Syndrome
06 novembre 2024
1 mn de lecture